Astellas Pharma Inc.【JP:4503】Cash flow
Market cap
¥4.05T
P/E ratio
22.3x
| 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Depreciation & amortization | - | - | - | - | - | 64,863 | 63,458 | 66,396 | 72,652 | 79,684 | 105,738 | 157,840 | 199,132 |
| Cash from operations | 150,926 | 214,257 | 187,686 | 313,737 | 235,612 | 312,614 | 258,630 | 221,998 | 306,843 | 257,444 | 327,767 | 172,475 | 194,512 |
| Capital expenditures | - | - | - | - | - | -25,077 | -25,190 | -41,267 | -31,384 | -30,739 | -36,441 | -38,056 | -37,003 |
| Cash from investing | -55,101 | -26,851 | -71,476 | -147,050 | -73,383 | -121,799 | -41,757 | -389,793 | -81,894 | -62,413 | -84,500 | -845,802 | -89,419 |
| Repurchases of common stock | - | - | - | - | - | -130,712 | -160,442 | -52,899 | -9,163 | -50,717 | -60,556 | -10,735 | -6,960 |
| Proceeds from issuance of term debt, net | - | - | - | - | - | - | - | - | 80,000 | - | - | - | - |
| Repayments of term debt | - | - | - | - | - | - | - | - | - | -30,000 | - | - | - |
| Cash from financing | -110,013 | -89,395 | -121,118 | -193,478 | -166,153 | -203,429 | -233,681 | 181,055 | -229,479 | -216,298 | -195,623 | 614,060 | -261,367 |